We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Pulmonary Veins Ablation Alone Sufficient for Persistent AF

By HospiMedica International staff writers
Posted on 17 Sep 2014
Catheter ablation of the pulmonary veins alone can improve outcomes in around half of those suffering from persistent atrial fibrillation (AF), according to a new study. More...


Researchers at Southlake Regional Health Center (Newmarket, Canada), the German Heart Center (Munich, Germany), and other institutions participating in the STAR AF 2 study randomized 589 patients (median age 58, 22% women) to pulmonary vein isolation (PVI, 64 patients) alone, PVI plus ablation by complex fractionated electrogram (PVI-CFE, 254 patients), or PVI plus empiric linear ablation of lesions in the left atrium (PVI-lines, 250 patients).


The results showed that successful PVI was achieved in 97% of all patients with no differences between groups. However, procedural time was significantly shorter for the PVI alone group (167 minutes) compared to the PVA-CFE (229 minutes) and PVI plus lines (223 minutes) groups. The study also found that patients did not benefit from further ablation, since it increased treatment time and did not reduce AF recurrence. The study was presented at the European Society of Cardiology (ESC) congress, held during August-September 2014 in Barcelona (Spain).

“Among patients with persistent atrial fibrillation, freedom from recurrent atrial fibrillation was achieved in 59% of participants with PVI alone. Additional CFE or lines ablation added to procedure/fluoroscopy time, without improving freedom from atrial fibrillation,” said lead author and study presenter Atul Verma. “The results may ‘force’ a change in guideline thinking and a shift in practice to shorter and more effective pulmonary vein ablation without the addition of other ablation.”

PVI is a catheter ablation technique developed to prevent focal triggers in the pulmonary veins from initiating episodes of AF. Although the procedure initially involved ablation with a catheter directly in the pulmonary veins, isolating the pulmonary veins by applying ablation energy at their junction with the left atrium is more effective. The PVI procedure is most suitable for patients whose recurring symptomatic episodes of AF have not been suppressed by antiarrhythmic drugs, or who do not wish to take long-term antiarrhythmic or anticoagulation medications.

Related Links:

Southlake Regional Health Center
German Heart Center



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.